| Year |
Citation |
Score |
| 2023 |
Man KNM, Bartels P, Henderson PB, Kim K, Shi M, Zhang M, Ho SY, Nieves-Cintron M, Navedo MF, Horne MC, Hell JW. a adrenergic receptor - PKC - Pyk2 - Src signaling boosts L-type Ca channel Ca1.2 activity and long-term potentiation in rodents. Elife. 12. PMID 37338965 DOI: 10.7554/eLife.79648 |
0.782 |
|
| 2022 |
Bartels P, Salveson I, Coleman AM, Anderson DE, Jeng G, Estrada-Tobar ZM, Mimi Man KN, Yu Q, Kuzmenkina E, Nieves-Cintron M, Navedo MF, Horne MC, Hell JW, Ames JB. Half-calcified calmodulin promotes basal activity and inactivation of the L-type calcium channel Ca1.2. The Journal of Biological Chemistry. 102701. PMID 36395884 DOI: 10.1016/j.jbc.2022.102701 |
0.68 |
|
| 2022 |
Pereira da Silva EA, Martín-Aragón Baudel M, Hong J, Bartels P, Navedo MF, Nieves-Cintrón M. Vascular Ca1.2 channels in diabetes. Current Topics in Membranes. 90: 65-93. PMID 36368875 DOI: 10.1016/bs.ctm.2022.09.003 |
0.314 |
|
| 2022 |
Wang S, Bartels P, Zhao C, Yousuf A, Liu Z, Yu S, Bony AR, Ma X, Dai Q, Sun T, Liu N, Yang M, Yu R, Du W, Adams DJ, et al. A 4/8 Subtype α-Conotoxin Vt1.27 Inhibits N-Type Calcium Channels With Potent Anti-Allodynic Effect. Frontiers in Pharmacology. 13: 881732. PMID 35754473 DOI: 10.3389/fphar.2022.881732 |
0.704 |
|
| 2021 |
Belgi A, Burnley JV, MacRaild CA, Chhabra S, Elnahriry KA, Robinson SD, Gooding SG, Tae HS, Bartels P, Sadeghi M, Zhao FY, Wei H, Spanswick D, Adams DJ, Norton RS, et al. Alkyne-Bridged α-Conotoxin Vc1.1 Potently Reverses Mechanical Allodynia in Neuropathic Pain Models. Journal of Medicinal Chemistry. PMID 33724033 DOI: 10.1021/acs.jmedchem.0c02151 |
0.788 |
|
| 2020 |
Man KNM, Bartels P, Horne MC, Hell JW. Tissue-specific adrenergic regulation of the L-type Ca channel Ca1.2. Science Signaling. 13. PMID 33443233 DOI: 10.1126/scisignal.abc6438 |
0.811 |
|
| 2020 |
Turner M, Anderson DE, Bartels P, Nieves-Cintron M, Coleman AM, Henderson PB, Man KNM, Tseng PY, Yarov-Yarovoy V, Bers DM, Navedo MF, Horne MC, Ames JB, Hell JW. α-Actinin-1 promotes activity of the L-type Ca channel Ca1.2. The Embo Journal. 39: e106171. PMID 33433005 DOI: 10.15252/embj.2020106171 |
0.799 |
|
| 2020 |
Prada MP, Syed AU, Reddy GR, Martín-Aragón Baudel M, Flores-Tamez VA, Sasse KC, Ward SM, Sirish P, Chiamvimonvat N, Bartels P, Dickson EJ, Hell JW, Scott JD, Santana LF, Xiang YK, et al. AKAP5 complex facilitates purinergic modulation of vascular L-type Ca channel Ca1.2. Nature Communications. 11: 5303. PMID 33082339 DOI: 10.1038/s41467-020-18947-y |
0.681 |
|
| 2020 |
Turner M, Anderson DE, Bartels P, Nieves-Cintron M, Coleman AM, Henderson PB, Man KNM, Tseng PY, Yarov-Yarovoy V, Bers DM, Navedo MF, Horne MC, Ames JB, Hell JW. α-Actinin-1 promotes activity of the L-type Ca channel Ca 1.2. The Embo Journal. e102622. PMID 31985069 DOI: 10.15252/Embj.2019102622 |
0.804 |
|
| 2020 |
Turner M, Anderson DE, Bartels P, Nieves‐Cintron M, Coleman AM, Henderson PB, Man KNM, Tseng P, Yarov‐Yarovoy V, Bers DM, Navedo MF, Horne MC, Ames JB, Hell JW. α‐Actinin‐1 promotes activity of the L‐type Ca
2+
channel Ca
v
1.2 The Embo Journal. 39. DOI: 10.15252/embj.2020106171 |
0.496 |
|
| 2019 |
Shen A, Chen D, Kaur M, Bartels P, Xu B, Shi Q, Martinez JM, Man KM, Nieves-Cintron M, Hell JW, Navedo MF, Yu X, Xiang YK. β-blockers augment L-type Ca channel activity by targeting spatially restricted βAR signaling in neurons. Elife. 8. PMID 31609201 DOI: 10.7554/eLife.49464 |
0.779 |
|
| 2019 |
Dai Q, Liu Z, Ning H, Bartels P, Li L, Tang Y, Yu S, Sadeghi M, Zhang L, Du T, Huang B, Jiang L, Guo C, Adams DJ. Structures, functions of two novel α-conotoxins from conus snails in South China Sea Toxicon. 158: S26-S27. DOI: 10.1016/J.Toxicon.2018.10.096 |
0.686 |
|
| 2018 |
Bartels P, Yu D, Huang H, Hu Z, Herzig S, Soong TW. Alternative Splicing at N Terminus and Domain I Modulates Ca1.2 Inactivation and Surface Expression. Biophysical Journal. 115: 163. PMID 29972807 DOI: 10.1016/j.bpj.2018.06.001 |
0.708 |
|
| 2018 |
Bartels P, Yu D, Huang H, Hu Z, Herzig S, Soong TW. Alternative Splicing at N Terminus and Domain I Modulates Ca1.2 Inactivation and Surface Expression. Biophysical Journal. 114: 2095-2106. PMID 29742403 DOI: 10.1016/J.Bpj.2018.03.029 |
0.756 |
|
| 2018 |
Liu Z, Bartels P, Sadeghi M, Du T, Dai Q, Zhu C, Yu S, Wang S, Dong M, Sun T, Guo J, Peng S, Jiang L, Adams DJ, Dai Q. A novel α-conopeptide Eu1.6 inhibits N-type (CaV2.2) calcium channels and exhibits potent analgesic activity. Scientific Reports. 8: 1004. PMID 29343689 DOI: 10.1038/S41598-017-18479-4 |
0.783 |
|
| 2017 |
Li G, Wang J, Liao P, Bartels P, Zhang H, Yu D, Liang MC, Poh KK, Yu CY, Jiang F, Yong TF, Wong YP, Hu Z, Huang H, Zhang G, et al. Exclusion of alternative exon 33 of CaV1.2 calcium channels in heart is proarrhythmogenic. Proceedings of the National Academy of Sciences of the United States of America. PMID 28490495 DOI: 10.1073/Pnas.1617205114 |
0.709 |
|
| 2014 |
Chhabra S, Belgi A, Bartels P, van Lierop BJ, Robinson SD, Kompella SN, Hung A, Callaghan BP, Adams DJ, Robinson AJ, Norton RS. Dicarba analogues of α-conotoxin RgIA. Structure, stability, and activity at potential pain targets. Journal of Medicinal Chemistry. 57: 9933-44. PMID 25393758 DOI: 10.1021/Jm501126U |
0.776 |
|
| 2009 |
Bartels P, Behnke K, Michels G, Groner F, Schneider T, Henry M, Barrett PQ, Kang HW, Lee JH, Wiesen MH, Matthes J, Herzig S. Structural and biophysical determinants of single Ca(V)3.1 and Ca(V)3.2 T-type calcium channel inhibition by N(2)O. Cell Calcium. 46: 293-302. PMID 19783046 DOI: 10.1016/J.Ceca.2009.09.002 |
0.708 |
|
| Show low-probability matches. |